This document discusses using analytics to track, monitor, and reduce costs in the healthcare industry. It begins with learning objectives about identifying misuse and abuse, using analytics to identify trends, how pharmacy benefit managers can use analytics, and predictive analytics in workers' compensation. The document then discusses challenges claims managers face with long-acting opioid prescriptions costing much more. It identifies 5 key problems claims managers encounter and how Rx Intelligence analytics can help address these problems by flagging potentially problematic claims early. The impact of successful peer-to-peer conversations on reduced prescription fills is also demonstrated.
University of Toledo Medical Center Patient Experience Improvement Strategic ...Ioan Duca
The document outlines UTMC's plan to improve service excellence from 2011-2012. It discusses analyzing performance data, aligning leadership to address issues, selecting engaged employees, and developing a patient-centered culture. The goals are to narrow gaps in outcomes vs experience, engage physicians and staff, and prepare for pay-for-performance programs emphasizing quality and satisfaction.
This document discusses opportunities to hack and improve healthcare through automation and improvements to supply chain systems. It notes that 62% of the $2.3 trillion annual healthcare spending in the US is on hospitals and doctors. There is $600 billion wasted annually through inefficiencies, bad care, and fraud. Specific opportunities called out include improving medical waste management with smart trash cans, automating drug dispensing with systems like Pyxis, using robots to help with tasks like pharmacy automation, and improving communication systems to increase throughput and safety like Vocera's voice badge system. The document advocates visiting hospital basements to find ways to hack and accelerate impact in healthcare.
Human clinical data is the critical proof for new medical treatments. The current pharma, venture capital and NIH funding environments make it more important than ever for capital efficient clinical trial design and funding. Here are some best practices in mapping new treatments to clinical applications to accelerate clinical trial data.
This document summarizes a presentation on workers' compensation policy issues and solutions related to opioids. It includes discussions from three presenters on topics like the Ohio Bureau of Workers' Compensation pharmacy program, physician dispensing of opioids, and policy reforms. The Ohio BWC program presentation describes the program's formulary changes from 2011-2014 to curb opioid utilization and other drug spending. It also evaluates the program's impact on reducing opioid prescriptions and medical costs. The physician dispensing presentation examines the financial incentives for dispensing and higher claim costs when physicians dispense opioids. It advocates for legislative reforms to curb dispensing to improve outcomes.
Rethink: Payer Strategies for Commercializing Cell and Gene TherapiesAmerisourceBergen
The document summarizes insights from a survey of 46 managed care executives on their perspectives and readiness for coverage of cell and gene therapies. Key findings include: most payers believe a separate process is needed to evaluate cell and gene therapies but none have completed the process; long-term outcomes data and total therapy costs are seen as major barriers to coverage; payers are considering outcomes-based agreements and annuity-based reimbursement models but lack resources for long-term outcomes monitoring; and cell and gene therapy innovators need to proactively work with payers to shape evaluation, payment models, and access to these new therapies.
This document provides best practices for independent oncology practices to increase referrals from hospital-affiliated physicians. It outlines a four-pronged strategy of excellent service, outreach, convenience, and cost considerations. Excellent service includes outstanding patient care, quick turnaround times, and communication with referrers. Outreach involves hospital presence, referrer meetings, community involvement, and promotion. Convenience recommends a one-stop shop, proximity to patients, and multiple locations. Regarding cost, the document suggests accepting more insurance plans and staying attractive to payers to compete with hospitals. Data analysis tools can help implement these strategies effectively.
The document discusses plans to create a program called "Hacking Medicine" at MIT and Harvard to teach students how to develop medical technology solutions. The program aims to provide an ecosystem for students to collaborate with clinical and domain experts worldwide to learn and rapidly develop solutions to meet unique medical needs and challenges. Healthcare is a complex industry with many fragmented players and barriers. The hacking culture and entrepreneurial environment at MIT provides an opportunity to include life science outsiders and drive innovation. The time is right for students to hack healthcare due to rising costs driving reform, incentives changing, and information technology intersecting with healthcare and business models.
Predicting Patient Adherence: Why and HowCognizant
To contain costs and improve healthcare outcomes, players across the value chain must apply advanced analytics to measure and understand patients’ failure to follow treatment therapies, and to then determine effective remedial action. This white paper lays out a framework for enabling patient adherence management and some general prescriptions on how to convert lofty concepts to meaningful action.
University of Toledo Medical Center Patient Experience Improvement Strategic ...Ioan Duca
The document outlines UTMC's plan to improve service excellence from 2011-2012. It discusses analyzing performance data, aligning leadership to address issues, selecting engaged employees, and developing a patient-centered culture. The goals are to narrow gaps in outcomes vs experience, engage physicians and staff, and prepare for pay-for-performance programs emphasizing quality and satisfaction.
This document discusses opportunities to hack and improve healthcare through automation and improvements to supply chain systems. It notes that 62% of the $2.3 trillion annual healthcare spending in the US is on hospitals and doctors. There is $600 billion wasted annually through inefficiencies, bad care, and fraud. Specific opportunities called out include improving medical waste management with smart trash cans, automating drug dispensing with systems like Pyxis, using robots to help with tasks like pharmacy automation, and improving communication systems to increase throughput and safety like Vocera's voice badge system. The document advocates visiting hospital basements to find ways to hack and accelerate impact in healthcare.
Human clinical data is the critical proof for new medical treatments. The current pharma, venture capital and NIH funding environments make it more important than ever for capital efficient clinical trial design and funding. Here are some best practices in mapping new treatments to clinical applications to accelerate clinical trial data.
This document summarizes a presentation on workers' compensation policy issues and solutions related to opioids. It includes discussions from three presenters on topics like the Ohio Bureau of Workers' Compensation pharmacy program, physician dispensing of opioids, and policy reforms. The Ohio BWC program presentation describes the program's formulary changes from 2011-2014 to curb opioid utilization and other drug spending. It also evaluates the program's impact on reducing opioid prescriptions and medical costs. The physician dispensing presentation examines the financial incentives for dispensing and higher claim costs when physicians dispense opioids. It advocates for legislative reforms to curb dispensing to improve outcomes.
Rethink: Payer Strategies for Commercializing Cell and Gene TherapiesAmerisourceBergen
The document summarizes insights from a survey of 46 managed care executives on their perspectives and readiness for coverage of cell and gene therapies. Key findings include: most payers believe a separate process is needed to evaluate cell and gene therapies but none have completed the process; long-term outcomes data and total therapy costs are seen as major barriers to coverage; payers are considering outcomes-based agreements and annuity-based reimbursement models but lack resources for long-term outcomes monitoring; and cell and gene therapy innovators need to proactively work with payers to shape evaluation, payment models, and access to these new therapies.
This document provides best practices for independent oncology practices to increase referrals from hospital-affiliated physicians. It outlines a four-pronged strategy of excellent service, outreach, convenience, and cost considerations. Excellent service includes outstanding patient care, quick turnaround times, and communication with referrers. Outreach involves hospital presence, referrer meetings, community involvement, and promotion. Convenience recommends a one-stop shop, proximity to patients, and multiple locations. Regarding cost, the document suggests accepting more insurance plans and staying attractive to payers to compete with hospitals. Data analysis tools can help implement these strategies effectively.
The document discusses plans to create a program called "Hacking Medicine" at MIT and Harvard to teach students how to develop medical technology solutions. The program aims to provide an ecosystem for students to collaborate with clinical and domain experts worldwide to learn and rapidly develop solutions to meet unique medical needs and challenges. Healthcare is a complex industry with many fragmented players and barriers. The hacking culture and entrepreneurial environment at MIT provides an opportunity to include life science outsiders and drive innovation. The time is right for students to hack healthcare due to rising costs driving reform, incentives changing, and information technology intersecting with healthcare and business models.
Predicting Patient Adherence: Why and HowCognizant
To contain costs and improve healthcare outcomes, players across the value chain must apply advanced analytics to measure and understand patients’ failure to follow treatment therapies, and to then determine effective remedial action. This white paper lays out a framework for enabling patient adherence management and some general prescriptions on how to convert lofty concepts to meaningful action.
Manufacturer M chose to outsource many functions like logistics, storage, and reimbursement support to focus on drug discovery. This partner approach helped launch their new orphan drug successfully. The partner was able to ship enough orders within 6 hours to fill demand from specialty pharmacies, normally a 48 hour process. Patient initiations exceeded 101% of targets in the first quarter. Outsourcing allowed Manufacturer M to scale patient support quickly. Cultural alignment between the companies helped ensure a patient received treatment just before an important trip.
How pharma and healthcare brands can improve their customer experienceJack Morton Worldwide
The SVP and Managing Director of Jack’s Chicago office, Matt Pensinger, presented at Lions Health 2015 with Katie Bang from Eli Lilly and Company about improving the customer experience for patients:
There is growing recognition amongst healthcare brands that understanding the full patient journey is essential for success in today’s healthcare environment. The sheer extent of this both physical and emotional journey, from awareness through to treatment and adherence, opens the patient to many potential experience gaps between their expectations and reality that can lead to frustration, disillusionment and even dropping the prescribed treatment.
So, healthcare companies must understand this journey if they are to improve the customer experience – and offer necessary patient support that extends far beyond a given medication. Being truly effective requires that the entire organisation (from science through to sales) understands the patient journey in order to meet patient needs and effectively engage the many stakeholders that are becoming increasingly important to a therapy’s success.
This is a significant undertaking and healthcare brands and their marketing agencies need to think differently about how they engage with patients and support communications for all the other stakeholders. This talk will examine the experience journey and what it means for the way we market.
The emerging healthcare environment requires expanded patient access while delivering optimal outcomes and cost. As healthcare moves form a fee for service model to alternative delivery and payment models, there are opportunities for physical therapy to revolutionize the delivery of musculoskeletal medicine. Physical therapists are uniquely qualified to spearhead musculoskeletal care through direct access with the potential to improve patient satisfaction and outcomes while limiting unneeded medical care. While this model has been described in the military, there are few descriptions of this PT First approach in the private payer arena. This session will provide the attendee with a multifaceted perspective on the impact of physical therapy in emerging, collaborative healthcare models. Approaches to payers and employers with the business implications will be presented that influence these new models. Key strategies to implement a scalable, best practice model will be discussed including the logistical challenges and corollary solutions in the private arena. We will discus our experience implementing novel delivery models for management of neck, back, shoulder and knee pain. The session will deliver practical solutions to the challenges of implementing, assessing, and adapting a theoretical construct to a working viable program. Finally, the session will discuss how the use of a a large Patient Outcomes Registry and analysis of “big data” can drive best practice and inform development of the program.
Lessening the Negative Impact of Human Factors Linking Staffing Variables & P...API Healthcare
This document discusses how human factors such as staffing levels, skill mix, and competency assessment are frequently cited as root causes of medical errors based on reviews of sentinel events. It summarizes research showing connections between various staffing variables like nurse-to-patient ratios, overtime, experience levels, and patient outcomes including falls, hospital-acquired infections, pressure ulcers, mortality, readmissions, and length of stay. The document advocates for data-driven workforce management strategies like acuity-based staffing and competency management to optimize staffing and improve patient outcomes.
The Physician Value Index. A Tool for Effective Physician Integration. pscisolutions
Discover a new way to measure physician performance, and align physicians in context with patient satisfaction, quality-of-care measures and overall hospital financial performance.
Third-Party Track: A Tale of Two Companies, National Rx Drug Abuse Summit, April 2-4, 2013, Presentation by Jim Andrews, Dave Smith, Michael Gavin and Ron Mazariegos
This document provides an overview of ambulatory surgery centers (ASCs). It defines ASCs and discusses their growth and procedures performed. ASCs are less expensive alternatives to hospitals that specialize in outpatient surgeries. The document summarizes ASC ownership structures, regulatory environment, risk management, insurance, valuation methods, operations considerations, and financial objectives. ASCs aim to maximize the contribution margin per procedure through specialization, scale, and cost-efficiency.
The document discusses several challenges and opportunities in the genomics field, including issues scaling genomic data analysis, tensions around data sharing, and the massive costs required for patient awareness and activation. It also profiles two leaders in the genomics space, highlighting their backgrounds and roles in advising on precision medicine opportunities and investments.
This document summarizes clinical trial results for a medical device called dermaPACE that uses shockwave technology to treat diabetic foot ulcers. Some key points:
- A supplemental clinical trial of dermaPACE enrolled 130 patients and showed a complete wound closure rate of 22.7% for those treated with dermaPACE versus 18.3% for controls at 12 weeks.
- When combining results from the original and supplemental trials (total 336 patients), treatment with dermaPACE resulted in a statistically significant higher complete wound closure rate of 37.8% versus 26.2% for controls at 24 weeks.
- Subgroup analyses found higher wound closure rates with dermaPACE treatment for those
Designing Winning "Transitions of Care" Processes!PAFP
2013 PAFP Regional Lectures Series
Session 2 - Southeast
Learn about best practices for transitions of care, how to bill for the new management codes payable by Medicare.
Bonus: pick up great resources to improve management.
Speaker:
Lee Radosh, MD, FAAFP
Reading Hospital – Family Health Care Center
West Reading, PA
Patient experience has become increasingly important in healthcare. To improve patient experience, healthcare providers need to shift to a patient-centric model that focuses on all touchpoints of a patient's experience, from booking appointments to treatment and follow up. This requires training staff, enhancing technologies, personalizing care, and using data and feedback to continuously monitor and improve the patient experience.
Quantifying Value Drivers for Biopharmaceutical ProductsLaurie Gelb
The document discusses using heuristics rather than static profiles to better understand how physicians make drug treatment decisions. It argues that physicians consider attributes sequentially rather than simultaneously, and use mental shortcuts and reference points. The document advocates for eliciting physicians' own salient domains, measures, and threshold values to better quantify treatment preferences and forecast drug value in early-stage research. This approach provides more actionable insights than traditional conjoint analysis.
1) The article discusses concerns with tying individual physician performance to scores from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) surveys as directed by the Affordable Care Act.
2) The concerns center around the survey's use of an extrinsic rather than intrinsic approach, measurement issues around attributing scores to individual physicians, and potential unintended consequences such as focus on scores over quality.
3) The authors suggest allowing an opt-out pathway for organizations to develop their own internal patient experience measures as an alternative to the CG-CAHPS program.
Presentations from the first VIT-MIT-MGH Healthcare Hackathon. Healthcare and Medical Design Thinking to help scale medicine and spur innovations that can impact healthcare in India, China & emerging healthcare systems.
The State of Consumer Healthcare: A Study of Patient ExperienceProphet
Providers must deliver a holistic patient experience that extends beyond clinical care interactions. The current state of the patient experience is poor and getting worse according to surveys, with 81% of consumers unsatisfied. While providers see patient experience as important, they overestimate their performance by over 20 percentage points compared to consumer ratings. Improving patient experience can drive operational efficiencies and reduce costs while helping organizations achieve their missions. Providers must take a holistic view of patient experience, empower their staff, and thoughtfully invest in technologies to enhance the experience.
Healthcare Sector Update - January 2016Duff & Phelps
The S&P Healthcare Services Index decreased 6.9% over the last month, underperforming the S&P 500, which decreased 5.1% over the same period. Healthcare REITs had the highest valuation multiples (12.11x LTM Revenue, 17.1x LTM EBITDA).
HIMSS - Real Payer and Provider Collaborations - FinalDaniel Abdul
This document summarizes an upcoming event from HIMSS MN on the role of providers and payers in improving health outcomes through interoperability. The event will feature Daniel Abdul from UCare discussing challenges with interoperability including different views of data, missing clinical notes, and proprietary standards slowing progress. Abdul argues that truly putting patients first requires a unified view of their information and goals across all care teams. Security concerns cannot be an excuse for inaction on interoperability which is necessary to improve chronic care, reduce redundant questions, and enable learning from patient outcomes. The future requires information sharing in near real-time based on patient preferences.
Healthcare Sector Update - December 2015Duff & Phelps
While the S&P 500 increased 4.6% over the last three months, several factors drove far greater appreciation of diagnostic imaging device shares, which outperformed the S&P by 26%. However, challenges that stifle future performance provide an overhang.
Healthcare Services Sector Update - December 2016Duff & Phelps
The S&P Healthcare Services Index increased 1.2% over the past month, underperforming the S&P 500, which increased 1.8% over the same period. The best performing sectors were Skilled Nursing (up 9.7%), Diagnostic Imaging (up 9.3%) and Home Care / Hospice (up 8.0%).
This document summarizes opioid prescribing education programs in Massachusetts. It describes (1) a program that used Objective Structured Clinical Exams (OSCEs) to train internal medicine residents and faculty on safe opioid prescribing, finding it increased trainees' confidence and improved practices; (2) statewide 1/2-day physician trainings attended by over 1,275 clinicians; and (3) an online training program at opioidprescribing.com that has been completed by over 8,000 health professionals, most of whom are physicians. The goal of these programs is to improve opioid prescribing safety and help address the increasing problems of prescription opioid misuse and overdose.
The VHA National Pain Management Strategy outlines a stepped care model for managing pain across the VHA system. This involves establishing an infrastructure with defined roles and responsibilities at the national, VISN, and facility levels to coordinate a comprehensive, multidisciplinary approach to pain care. The goal is to provide timely access to evidence-based pain assessment, treatment, and follow-up utilizing primary care and specialty-level services tailored to patients' needs.
Manufacturer M chose to outsource many functions like logistics, storage, and reimbursement support to focus on drug discovery. This partner approach helped launch their new orphan drug successfully. The partner was able to ship enough orders within 6 hours to fill demand from specialty pharmacies, normally a 48 hour process. Patient initiations exceeded 101% of targets in the first quarter. Outsourcing allowed Manufacturer M to scale patient support quickly. Cultural alignment between the companies helped ensure a patient received treatment just before an important trip.
How pharma and healthcare brands can improve their customer experienceJack Morton Worldwide
The SVP and Managing Director of Jack’s Chicago office, Matt Pensinger, presented at Lions Health 2015 with Katie Bang from Eli Lilly and Company about improving the customer experience for patients:
There is growing recognition amongst healthcare brands that understanding the full patient journey is essential for success in today’s healthcare environment. The sheer extent of this both physical and emotional journey, from awareness through to treatment and adherence, opens the patient to many potential experience gaps between their expectations and reality that can lead to frustration, disillusionment and even dropping the prescribed treatment.
So, healthcare companies must understand this journey if they are to improve the customer experience – and offer necessary patient support that extends far beyond a given medication. Being truly effective requires that the entire organisation (from science through to sales) understands the patient journey in order to meet patient needs and effectively engage the many stakeholders that are becoming increasingly important to a therapy’s success.
This is a significant undertaking and healthcare brands and their marketing agencies need to think differently about how they engage with patients and support communications for all the other stakeholders. This talk will examine the experience journey and what it means for the way we market.
The emerging healthcare environment requires expanded patient access while delivering optimal outcomes and cost. As healthcare moves form a fee for service model to alternative delivery and payment models, there are opportunities for physical therapy to revolutionize the delivery of musculoskeletal medicine. Physical therapists are uniquely qualified to spearhead musculoskeletal care through direct access with the potential to improve patient satisfaction and outcomes while limiting unneeded medical care. While this model has been described in the military, there are few descriptions of this PT First approach in the private payer arena. This session will provide the attendee with a multifaceted perspective on the impact of physical therapy in emerging, collaborative healthcare models. Approaches to payers and employers with the business implications will be presented that influence these new models. Key strategies to implement a scalable, best practice model will be discussed including the logistical challenges and corollary solutions in the private arena. We will discus our experience implementing novel delivery models for management of neck, back, shoulder and knee pain. The session will deliver practical solutions to the challenges of implementing, assessing, and adapting a theoretical construct to a working viable program. Finally, the session will discuss how the use of a a large Patient Outcomes Registry and analysis of “big data” can drive best practice and inform development of the program.
Lessening the Negative Impact of Human Factors Linking Staffing Variables & P...API Healthcare
This document discusses how human factors such as staffing levels, skill mix, and competency assessment are frequently cited as root causes of medical errors based on reviews of sentinel events. It summarizes research showing connections between various staffing variables like nurse-to-patient ratios, overtime, experience levels, and patient outcomes including falls, hospital-acquired infections, pressure ulcers, mortality, readmissions, and length of stay. The document advocates for data-driven workforce management strategies like acuity-based staffing and competency management to optimize staffing and improve patient outcomes.
The Physician Value Index. A Tool for Effective Physician Integration. pscisolutions
Discover a new way to measure physician performance, and align physicians in context with patient satisfaction, quality-of-care measures and overall hospital financial performance.
Third-Party Track: A Tale of Two Companies, National Rx Drug Abuse Summit, April 2-4, 2013, Presentation by Jim Andrews, Dave Smith, Michael Gavin and Ron Mazariegos
This document provides an overview of ambulatory surgery centers (ASCs). It defines ASCs and discusses their growth and procedures performed. ASCs are less expensive alternatives to hospitals that specialize in outpatient surgeries. The document summarizes ASC ownership structures, regulatory environment, risk management, insurance, valuation methods, operations considerations, and financial objectives. ASCs aim to maximize the contribution margin per procedure through specialization, scale, and cost-efficiency.
The document discusses several challenges and opportunities in the genomics field, including issues scaling genomic data analysis, tensions around data sharing, and the massive costs required for patient awareness and activation. It also profiles two leaders in the genomics space, highlighting their backgrounds and roles in advising on precision medicine opportunities and investments.
This document summarizes clinical trial results for a medical device called dermaPACE that uses shockwave technology to treat diabetic foot ulcers. Some key points:
- A supplemental clinical trial of dermaPACE enrolled 130 patients and showed a complete wound closure rate of 22.7% for those treated with dermaPACE versus 18.3% for controls at 12 weeks.
- When combining results from the original and supplemental trials (total 336 patients), treatment with dermaPACE resulted in a statistically significant higher complete wound closure rate of 37.8% versus 26.2% for controls at 24 weeks.
- Subgroup analyses found higher wound closure rates with dermaPACE treatment for those
Designing Winning "Transitions of Care" Processes!PAFP
2013 PAFP Regional Lectures Series
Session 2 - Southeast
Learn about best practices for transitions of care, how to bill for the new management codes payable by Medicare.
Bonus: pick up great resources to improve management.
Speaker:
Lee Radosh, MD, FAAFP
Reading Hospital – Family Health Care Center
West Reading, PA
Patient experience has become increasingly important in healthcare. To improve patient experience, healthcare providers need to shift to a patient-centric model that focuses on all touchpoints of a patient's experience, from booking appointments to treatment and follow up. This requires training staff, enhancing technologies, personalizing care, and using data and feedback to continuously monitor and improve the patient experience.
Quantifying Value Drivers for Biopharmaceutical ProductsLaurie Gelb
The document discusses using heuristics rather than static profiles to better understand how physicians make drug treatment decisions. It argues that physicians consider attributes sequentially rather than simultaneously, and use mental shortcuts and reference points. The document advocates for eliciting physicians' own salient domains, measures, and threshold values to better quantify treatment preferences and forecast drug value in early-stage research. This approach provides more actionable insights than traditional conjoint analysis.
1) The article discusses concerns with tying individual physician performance to scores from the Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG-CAHPS) surveys as directed by the Affordable Care Act.
2) The concerns center around the survey's use of an extrinsic rather than intrinsic approach, measurement issues around attributing scores to individual physicians, and potential unintended consequences such as focus on scores over quality.
3) The authors suggest allowing an opt-out pathway for organizations to develop their own internal patient experience measures as an alternative to the CG-CAHPS program.
Presentations from the first VIT-MIT-MGH Healthcare Hackathon. Healthcare and Medical Design Thinking to help scale medicine and spur innovations that can impact healthcare in India, China & emerging healthcare systems.
The State of Consumer Healthcare: A Study of Patient ExperienceProphet
Providers must deliver a holistic patient experience that extends beyond clinical care interactions. The current state of the patient experience is poor and getting worse according to surveys, with 81% of consumers unsatisfied. While providers see patient experience as important, they overestimate their performance by over 20 percentage points compared to consumer ratings. Improving patient experience can drive operational efficiencies and reduce costs while helping organizations achieve their missions. Providers must take a holistic view of patient experience, empower their staff, and thoughtfully invest in technologies to enhance the experience.
Healthcare Sector Update - January 2016Duff & Phelps
The S&P Healthcare Services Index decreased 6.9% over the last month, underperforming the S&P 500, which decreased 5.1% over the same period. Healthcare REITs had the highest valuation multiples (12.11x LTM Revenue, 17.1x LTM EBITDA).
HIMSS - Real Payer and Provider Collaborations - FinalDaniel Abdul
This document summarizes an upcoming event from HIMSS MN on the role of providers and payers in improving health outcomes through interoperability. The event will feature Daniel Abdul from UCare discussing challenges with interoperability including different views of data, missing clinical notes, and proprietary standards slowing progress. Abdul argues that truly putting patients first requires a unified view of their information and goals across all care teams. Security concerns cannot be an excuse for inaction on interoperability which is necessary to improve chronic care, reduce redundant questions, and enable learning from patient outcomes. The future requires information sharing in near real-time based on patient preferences.
Healthcare Sector Update - December 2015Duff & Phelps
While the S&P 500 increased 4.6% over the last three months, several factors drove far greater appreciation of diagnostic imaging device shares, which outperformed the S&P by 26%. However, challenges that stifle future performance provide an overhang.
Healthcare Services Sector Update - December 2016Duff & Phelps
The S&P Healthcare Services Index increased 1.2% over the past month, underperforming the S&P 500, which increased 1.8% over the same period. The best performing sectors were Skilled Nursing (up 9.7%), Diagnostic Imaging (up 9.3%) and Home Care / Hospice (up 8.0%).
This document summarizes opioid prescribing education programs in Massachusetts. It describes (1) a program that used Objective Structured Clinical Exams (OSCEs) to train internal medicine residents and faculty on safe opioid prescribing, finding it increased trainees' confidence and improved practices; (2) statewide 1/2-day physician trainings attended by over 1,275 clinicians; and (3) an online training program at opioidprescribing.com that has been completed by over 8,000 health professionals, most of whom are physicians. The goal of these programs is to improve opioid prescribing safety and help address the increasing problems of prescription opioid misuse and overdose.
The VHA National Pain Management Strategy outlines a stepped care model for managing pain across the VHA system. This involves establishing an infrastructure with defined roles and responsibilities at the national, VISN, and facility levels to coordinate a comprehensive, multidisciplinary approach to pain care. The goal is to provide timely access to evidence-based pain assessment, treatment, and follow-up utilizing primary care and specialty-level services tailored to patients' needs.
The document summarizes the work of the NOPE Task Force, a non-profit organization working to reduce drug overdose deaths through community education, family support, and advocacy. It outlines their programs including presentations to schools, parents and healthcare professionals to raise awareness about prescription drug abuse. It also describes family support services and partnerships with law enforcement agencies. Evaluation findings indicate their programs are effective in changing knowledge and attitudes around drug use.
This document summarizes a presentation on prescription drug abuse given at a conference. It discusses national overdose statistics showing a large increase in overdose deaths. Common factors contributing to overdoses are mixing multiple drugs and reduced drug tolerance after being released from institutions. The presentation outlines a comprehensive response including law enforcement reviewing overdose deaths for criminal leads, public awareness campaigns, and quantitative research analyzing overdose cases. Research of 353 overdose cases found the typical profile is a middle-aged white male with a history of substance abuse issues. The most common circumstances involved dying at home from accidental overdoses combining drugs like oxycodone and alprazolam.
National Rx Drug Abuse Summit, April 2-4, 2013, General Session presentation "Realities of Addiction," by Dr. Nora Volkow, Director, National Institute on Drug Abuse
This document contains information about performance evaluation methods for a data controller, including examples of performance review phrases. It discusses 12 common methods for evaluating a data controller's performance: management by objectives, critical incident method, behaviorally anchored rating scales, behavioral observation scales, 360 degree appraisal, and checklist and weighted checklist methods. For each method, it provides details on how the method works and its advantages or disadvantages. It also includes several positive and negative examples of performance review phrases for various performance factors like attitude, decision-making, problem-solving, and teamwork.
Haiku Deck is a presentation platform that allows users to create Haiku-style slideshows. The document encourages the reader to get started creating their own Haiku Deck presentation on SlideShare by providing a link to do so. It aims to inspire the reader to try out Haiku Deck's unique presentation style.
This project aims to develop a wireless electric vehicle charging system with high efficiency (>85%), high power transfer (over 6.6 kW), and good position tolerance. The system achieved power transfer of 6.6 kW with 85% efficiency at a 20 cm coil gap in initial testing. Future work will reduce the coil size and increase power transfer capability to 19.2 kW while maintaining performance. Validation through building and testing 5 electric vehicles integrated with the wireless charging system is also planned.
El documento resume la situación económica y laboral actual en Venezuela. Menciona que el 98% de las personas trabaja entre 8-10 horas al día hasta los 60-64 años y que la mayoría se jubila con solo el 40% de sus ingresos. Además, indica que el 90% de las familias gana menos de 4.800 bolívares al mes y solo el 10% gana más de 12.000 bolívares. Finalmente, propone invertir en negocios de consumo masivo aprovechando que cada hogar gasta alrededor de 5.000 bolíva
Kyra Campbell (Imperial College London) - Understanding and Addressing Corrosion Due to Amine Solvents in Post-Combustion Carbon Capture Processes - UKCCSRC Cranfield Biannual 21-22 April 2015
This document contains materials for evaluating the job performance of a functional consultant, including:
1) A 4-page performance evaluation form with ratings for various performance factors and sections for comments.
2) A list of additional online resources for performance appraisals, including sample phrases, forms, and guides.
3) An 8-page section with example performance review phrases for evaluating a functional consultant's attitude, creativity, decision-making, and other skills.
The document provides a comprehensive template and resources for conducting a full performance review of a functional consultant's work.
The document provides guidance on confidentiality and when confidential information can be disclosed without patient consent under UK law and General Medical Council guidelines. It discusses the duty of confidentiality doctors have toward patient information, but notes there are exceptions where information can be disclosed to protect others from serious harm or death. Specific scenarios addressed include informing police if a sex offender does not intend to register their address as required, providing information for a case review investigating child abuse even if the family does not consent, and notifying licensing authorities if a patient's medical condition like a serious mental illness may impair their ability to drive. The document aims to help doctors balance patient confidentiality with protecting public safety.
Este documento analiza el programa Code for America, un colectivo que desarrolla productos tecnológicos para apoyar a los gobiernos. El autor señala que el éxito de este programa se debe menos a la pericia técnica y más a los valores que lo guían, como la acción colectiva y el mejorar la vida de los ciudadanos. También destaca que las aplicaciones creadas por este colectivo movilizan a los ciudadanos a participar en tareas como limpiar hidrantes o verificar alarmas, mejorando así la comunidad.
Debra Ann Weeks has extensive experience in technical and educational management positions. She has led multiple projects involving assay chemistry and instrumentation development. Weeks has also managed personnel, collaborated with vendors, and written technical reports. Additionally, she has experience as a consultant managing projects, developing applications, and designing analytical procedures and a laboratory facility. Weeks has successfully led projects while supervising engineers and scientists. She has also taught chemistry at several universities while developing new courses and improving student outcomes.
Daiwa Microtech Limited (DML) is a subsidiary of Daiwa Distribution Group established in August 2006 focused on electronics R&D associated with components distribution. DML aims to provide customers with technical support and turnkey solutions by leveraging its engineering resources. Key projects include developing an e-bike controller using Toshiba MCUs and motor driver boards, as well as a portable media player platform and MP3 host utilizing various Toshiba chips.
This document summarizes a presentation on the financial toll of prescription drug addiction from the perspective of third-party payers. It includes presentations from experts at the CDC, a private insurance company, and a university. The presentations outline national trends in opioid use and expenditures, strategies used by an insurance company to identify and manage high-risk opioid claims, and a description of North Carolina's Medicaid Lock-In Program aimed at curbing prescription drug misuse. The document provides disclosure statements for each presenter and learning objectives for the session.
Master Your Value-Based Care Strategy: Introducing Health Catalyst Value Opti...Health Catalyst
The document provides an overview of Health Catalyst's Value Optimizer product, which is a web-based application that aims to help healthcare organizations develop data-informed strategies for value-based care. It describes three key capabilities of Value Optimizer: 1) Creating a comprehensive, benchmarked strategy using complete data, 2) Providing transparent and actionable insights into total cost of care and contracts, and 3) Enabling exploration of various clinical areas to uncover opportunities. The document includes several use cases that demonstrate how Value Optimizer can be used to analyze areas like inpatient utilization, pharmacy spending, imaging utilization, and more. It also discusses the support services that Health Catalyst provides to help customers implement and optimize the Value Optimizer
Streamlining Your Medical Practice for Profitability and SuccessConventus
Conventus webinar video providing key success strategies and tactics for improving productivity, profitability, and patient care. The one-hour video features host Susan Lieberman of Conventus and Stevie Davidson of Health Informatics Consulting.
Many leading pharmaceutical companies recognize the need to explore different means and mechanisms to supply physicians and their patients with samples of prescription medications. This is especially true since many physicians have restricted access to the sales reps that traditionally helped order and restock samples as part of their detailing visits.
While some companies have made substantial forays into the world of physician e-sampling, usually as a supplement to traditional sampling, others have done less in this area. This is important when you consider that 30 percent of patients in the United States are more likely to fill a prescription after initially receiving a sample from a physician. This study identifies and documents current practices and trends in physician e-sampling and explores the rationale for different tactical approaches to sampling and what constitutes success in physician e-sampling.
Why Process Measures Are Often More Important Than Outcome Measures in Health...Health Catalyst
The healthcare industry is currently obsessed with outcome measures — and for good reason. But tracking outcome measures alone is insufficient to reach the goals of better quality and reduced costs. Instead, health systems must get more granular with their data by tracking process measures. Process measures make it possible to identify the root cause of a health system’s failures. They’re the checklists of systematically guaranteeing that the right care will be delivered to every patient, every time. By using these checklists, organizations will be able to improve quality and cost by reducing the amount of variation in care delivery.
Opportunity analysis uses data to identify potential improvement initiatives and quantifies the value of these initiatives—both in terms of patient care benefits and financial impact. This process is an effective way to find unwarranted and costly clinical variation and, in turn, develop strategies to reduce it, improving outcomes and saving costs along the way. Standardizing the opportunity analysis process makes it repeatable and prioritizes actionable opportunities.
Quarterly opportunity analysis should follow four steps:
Kicking off the analysis by getting analysts together to do preliminary analysis and brainstorm.
Engaging with clinicians to identify opportunities and, in the process, get clinician buy in.
Digging deeper into the suggested opportunities to prioritize those that offer the greatest benefits.
Presenting findings to the decision makers.
Dr Ayman Ewies - Clinical audit made easyAymanEwies
This document provides an overview of how to conduct a clinical audit. It defines clinical audit as a process used by healthcare professionals to systematically review, evaluate and improve patient care. The document outlines the key components of an audit, including choosing a topic, selecting standards, planning methodology, collecting data, analyzing results, and implementing changes. It emphasizes that the goal of audit is to compare current practices to standards in order to enhance quality of care and patient outcomes.
5 Vital Tips to Help Reduce Readmissions in HospitalsJuran Global
This document provides tips for reducing hospital readmissions. It discusses the importance of accurately analyzing the root causes of readmission problems using valid data and proven methods like Six Sigma. The first tip is that there are no "magic bullets" and organizations need to properly diagnose issues before implementing solutions. Additional tips include engaging a multi-functional team to address readmissions and ensuring leadership support. Data analysis methods like process mapping and cause-and-effect diagrams are recommended to identify factors contributing to excess readmissions. Overall the document emphasizes the need for rigorous problem analysis over quick fixes in order to successfully reduce readmission rates.
1) Current state of quality and safety in healthcare is poor, with routine safety processes failing regularly and preventable adverse events occurring commonly.
2) High reliability organizations like commercial aviation have achieved much higher levels of safety through effective process improvement, a strong safety culture, and principles of collective mindfulness.
3) The Joint Commission aims to transform healthcare into a high reliability industry through initiatives like robust quality measurement, establishing accountability criteria for measures, and promoting high reliability principles.
This document provides an overview of clinical governance, which refers to the framework through which healthcare organizations ensure high quality care. It discusses key themes of clinical governance including clinical audit, risk management, evidence-based practice, staff training, and patient involvement. The document also describes services from Advanced Clinical Solutions related to clinical governance implementation and training.
Presentation for spbt 2013 meeting background and researchklaffy
The document discusses the changing context of medical practice and the need for pharmaceutical representatives to build value-based relationships with physicians. It provides guidance on how representatives can validate their clinical knowledge through sub-specialty certification programs. The document also summarizes research that found physicians are more likely to meet with representatives who have completed specialized training programs developed by medical societies. Finally, it outlines the structure and attributes of an ideal disease-state training program for representatives.
Mobile companion apps can be used to extend the patient-provider relationship beyond traditional in-person interactions. However, past health apps have often failed because they were disconnected from existing health records and clinical workflows. Effective companion apps would need to integrate with electronic health record systems used by providers and address how doctors would use the apps as part of their existing practices. Developing companion apps can help improve patient engagement, satisfaction, and trust in providers by providing information to patients before and after visits and strengthening the personal connection in healthcare.
Pharmacovigilance: Regulators’ Perspective on Proactive Risk Management, Chal...Bhaswat Chakraborty
The prescription drug sales have been growing globally at a rate of 12-20%, which is lucrative by any standards, especially when top companies’ total sales are approaching 25-40 billion USD a year. Such market forces create tremendous pressure on one side on the drug sponsors to launch their product as early as possible, and on the other hand on the significantly regulators to decide on the product safety for approval with a tremendous time constraint. In such a scenario, drug regulatory authorities in US, Europe and elsewhere have renewed their mandate to fortify the “safety” regulations so that the drugs released to the market are highly safe and effective. The FDA Amendment Act, 2007 (FDAAA) have now authorized FDA to significantly increase the user fees for safety initiatives and evaluations. The FDA initiatives include its authority to ask from a drug sponsor a Risk and Evaluation Mitigation Strategy (REMS) with a detailed risk minimization action plan. FDA can now require the sponsor to develop a comprehensive safety surveillance system as well. For each new drug, FDA will now also establish an internal committee for a safe use of this drug in pediatric population. Similar approaches and authorities have also been given to European drug regulatory agencies.
This presentation will take you through the current proactive risk management approaches used or proposed by the prominent regulatory agencies for both pre- and post- market safety surveillance of new drug and new drug products. It will also discuss the challenges and collaborative efforts of both regulators and industry to work with a multidisciplinary safety management system to identify and assess the risk signals as early as possible in drug development process. Further it will discuss the reporting and evaluation of this data such that it helps pre-market approval of the safest possible product and a transparent post-market surveillance plan.
This document discusses engaging physicians in clinical redesign efforts to improve hospital finances. It begins by providing background on declining hospital margins in recent years and increasing financial pressures going forward. It then outlines six key steps to engaging physicians: 1) Define the need and vision; 2) Share detailed clinical cost data; 3) Establish shared authority and responsibility; 4) Provide structure and guidance through committees; 5) Focus on initiatives that reduce costs while maintaining or improving quality; 6) Incentivize physician participation. It emphasizes the importance of physician leadership and buy-in for successful redesign. It also addresses potential pitfalls and ways to gain physician alignment, such as addressing quality concerns, translating data effectively, and clarifying expectations around incentives
Making Healthcare Waste Reduction and Patient Safety Actionable - HAS Session 6Health Catalyst
Multiple studies have estimated that at least 30% of US healthcare expenditures are wasteful. But how do you identify and reduce that waste? In this session, we will share with you a three-part framework for understanding, measuring and addressing waste reduction. In particular, we will highlight the importance patient safety and injury prevention, framing the importance of shifting from a system of incident reporting (which creates a culture of blame and guilt) to a system in which patient injury is regarded as a process failure rather than a person failure. To make that transition, health systems will need to 1) define process flows and metrics for each major type of patient injury; and 2) create a learning environment in which team members are engaged in process redesign to prevent process failure and injury. A leading health system in patient safety and quality will also share their best practices in how they have created a culture of patient safety and quality.
This document outlines the process of clinical audit, which involves comparing aspects of patient care against explicit criteria to improve outcomes. It discusses establishing structure, measuring processes, and evaluating outcomes. The document also describes the audit cycle of preparing, selecting criteria, measuring performance, making improvements, and sustaining them over time. Clinical audit is presented as a way for healthcare professionals and organizations to critically examine practices and ensure patients receive optimal care.
Five Strategies for Easing the Burden of Clinical Quality MeasuresHealth Catalyst
Healthcare systems need to view regulatory measures in a different light. Rather than approaching them as required processes that burden the system, they should be viewed as quality improvement opportunities that lead to best practices. It helps to have a strategy to get there:
Prioritize measures that truly impact patient care
Have a line-of-sight to reimbursement
Understand measure alignment across programs
Involve the right people
Get involved in measure development upstream
The right tools also help, but a plan for success is advised for healthcare system administrators and clinicians who need to ease the reporting burden and take advantage of every measure in a positive way.
Dr. Tom Frieden, Director of the Centers for Disease Control and Prevention, keynote presentation at the National Rx Drug Abuse & Heroin Summit on March 30, 2016.
Kana Enomoto, Acting Administrator, Substance Abuse and Mental Health Services Administration, keynote presentation at the National Rx Drug Abuse & Heroin Summit March 29, 2016
This document summarizes a presentation on managing morphine equivalent dose (MED) and identifying high-risk opioid use through "red flagging." It discusses how calculating MED at the point of sale can help identify unsafe dosages and decrease opioid prescriptions. It also evaluates different methods to screen for overdose risk, finding that simple opioid use thresholds to flag patients may not accurately target those most likely to experience preventable overdoses. The presentation aims to explain MED management, describe payer solutions that reduced opioid use, and identify more precise ways to intervene with highest-risk patients.
Web rx16 prev_tues_330_1_lawal_2warren_3huddleston_4pershingOPUNITE
This document discusses the role of health departments in preventing neonatal abstinence syndrome (NAS). It notes that NAS rates have increased significantly in recent years, disproportionately affecting women. Health departments engage in surveillance to monitor NAS trends, partner with other organizations, support treatment and recovery programs, and provide education to prevent NAS, which is entirely preventable. The document outlines specific strategies health departments use across these areas to address the opioid epidemic and protect maternal and infant health.
The document discusses the opioid crisis in the United States, including rising rates of prescription opioid misuse and abuse, as well as heroin use and overdose deaths. It outlines how research can help address this crisis through developing less abusable analgesics, expanding access to treatment medications like naloxone and buprenorphine, and exploring new treatment approaches such as immunotherapies and precision medicine targeting genetic factors. The National Institute on Drug Abuse is supporting these research efforts and working to disseminate findings to improve prevention and intervention programs.
This document summarizes the opioid crisis in the United States from 2000 to 2014. It shows that the number of opioid-related overdose deaths more than tripled during this period, increasing from about 8,000 to over 28,000. Additionally, 7.9 million Americans aged 12 or older met the criteria for an illicit drug use disorder in 2013-2014 but only 20% received treatment. The document outlines actions by the Obama administration to address the crisis and increase funding for treatment. It emphasizes that stories can help reduce stigma and that recovery is possible through working together.
Web rx16 prev_tues_200_1_bretthaude-mueller_2scott_3debenedittis_4cairnes copyOPUNITE
This presentation covered multi-media prevention strategies for issues like prescription drug overdoses. It discussed the CDC's digital Rx drug prevention campaign, best practices for digital messaging, and programs using expectancy challenge theory and media literacy education in schools. Presenters included representatives from the CDC, Media Literacy for Prevention, and the Hanley Center Foundation who discussed their work developing and implementing digital communications and single-session prevention programs.
This document discusses strategies for reducing buprenorphine diversion and pill mills while improving access to treatment. It notes that limiting access to buprenorphine treatment is associated with increased diversion, while expanded access to quality treatment decreases diversion and overdose deaths. The document recommends educating prescribers, using medically-derived prescribing standards, ensuring adequate insurance coverage of safe prescribing practices, and addressing diversion risks for other controlled medications. It argues against onerous new regulations that could limit treatment access. The goal is to identify and support high-quality treatment while prosecuting criminal operations.
This document summarizes a presentation on linking and mapping prescription drug monitoring program (PDMP) data. It discusses the benefits of linking PDMP data to clinical data, including improving patient safety, evaluating prescribing decisions, and assessing the impact of PDMP interventions. It describes challenges with linking data, such as obtaining consent and negotiating data use agreements. It also discusses Washington State's MAPPING OPIOID AND OTHER DRUG ISSUES (MOODI) tool, which integrates PDMP data with other databases to map and target treatment and overdose prevention efforts at the community level.
Rx16 prev wed_330_workplace issues and strategiesOPUNITE
This document discusses workplace issues related to prescription drug abuse and strategies for prevention. It begins with introductions of the presenters and moderators. The learning objectives are then outlined as understanding challenges of prescription drug abuse in the workplace, identifying prevention strategies, and describing programs available through SAMHSA. The document then covers topics such as the scope of prescription drug misuse among workers, risks to the workplace, prevention strategies employers can consider, and available resources from SAMHSA.
Web only rx16 pharma-wed_330_1_shelley_2atwood-harlessOPUNITE
This document discusses a presentation on pharmacy burglary, robbery, and diversion of prescription drugs. The presentation covers trends in prescription drug diversion, particularly those involving robbery and burglary of pharmacies. It identifies preventative measures to enhance pharmacy security and safety. Strategies to reduce pharmacy crimes are outlined. The offender perspective is examined based on interviews with convicted offenders. Routine activities theory is discussed as relating to suitable targets, capable guardians, and motivated offenders. Partnerships between regulatory agencies and law enforcement are emphasized as key to prevention efforts.
Linking and mapping PDMP data can provide several benefits but also faces challenges. Linking PDMP and clinical data allows for evaluating the impact of PDMP interventions on outcomes and prescribing decisions. However, obtaining permissions and data is difficult due to legal and resource barriers. Mapping PDMP data using GIS tools in Washington identified areas for targeting overdose prevention efforts by visualizing patterns in prescribing risks, treatment availability, and overdoses. Stakeholders used these maps to guide education and funding decisions. Sustaining these tools requires ongoing funding and expanding included data sources.
This document discusses drug court models and the role of law enforcement in drug courts. It begins with introductions from presenters and outlines learning objectives about explaining drug court operations and benefits, how law enforcement can utilize drug courts, and identifying best practices. The following sections provide details on drug court models, including how they integrate treatment into the justice system using a non-adversarial approach. Key components of drug courts are outlined, and presenters discuss issues like prescription drug and heroin abuse as well as outcomes from drug courts in reducing recidivism and saving money. Law enforcement can play roles in prevention, addressing domestic violence, and targeting the right populations for drug court involvement through assessment.
This document summarizes presentations from two communities - Huntington, WV and Camden County, NJ - on their responses to heroin crises. It outlines programs implemented in Huntington, including a harm reduction program, centralized information system, and drug court expansion. It also discusses the region's history with prescription drug abuse and rise in heroin and associated issues like hepatitis and neonatal abstinence syndrome. Long-term strategies proposed include expanding treatment services, promoting career opportunities for those in recovery, and preventing relapse through environmental design changes.
This document discusses neonatal abstinence syndrome (NAS) and universal maternal drug testing. It provides background information on NAS including trends showing large increases in incidence and costs associated with NAS. It outlines objectives related to describing NAS trends, identifying legislative activities impacting NAS, describing family planning for women in substance abuse treatment, and explaining a hospital program using universal drug testing. The document then covers topics including NAS symptoms, incidence and geographic trends, costs of NAS, opioid use in women of childbearing age, unintended pregnancy rates, contraceptive use among opioid users, and maternal drug exposure sources.
Web only rx16-adv_tues_330_1_elliott_2brunson_3willis_4deanOPUNITE
This document outlines an advocacy track presentation on activating communities to address prescription drug abuse. It provides biographies of the presenters and moderators and discloses any conflicts of interest. The learning objectives are to identify best practices for implementing CADCA's seven strategies for community change to impact prescription drug issues. It then provides examples of how various coalitions across the country are utilizing each of the seven strategies, such as providing education, enhancing skills, supporting communities, and changing policies.
This document discusses recovery ready ecosystems and recovery community organizations. It introduces presenters from Young People in Recovery and Hope House Treatment Track who will discuss interventions, prevention, and recovery programs. Examples of Young People in Recovery chapters, programs, and services are provided, including employment workshops, education workshops, housing workshops, and recovery support services. The document also discusses recovery community organizations and initiatives in Texas and Georgia, such as the Association of Persons Affected by Addiction in Dallas and the Georgia Council on Substance Abuse.
This document summarizes a presentation on health plan involvement in safe prescribing. It includes:
1) Presentations from medical experts on prescription drug abuse trends from medical examiner data and a tribal health system's safe prescribing program.
2) A discussion of health plan policies to reduce "red flag" medication combinations like opioids plus benzodiazepines through prior authorization, formulary changes, and provider restrictions.
3) Examples of one health plan's implementation of policies like restricting methadone prescriptions to pain specialists and removing carisoprodol from its formulary.
Lecture slide titled Fraud Risk Mitigation, Webinar Lecture Delivered at the Society for West African Internal Audit Practitioners (SWAIAP) on Wednesday, November 8, 2023.
5 Tips for Creating Standard Financial ReportsEasyReports
Well-crafted financial reports serve as vital tools for decision-making and transparency within an organization. By following the undermentioned tips, you can create standardized financial reports that effectively communicate your company's financial health and performance to stakeholders.
Economic Risk Factor Update: June 2024 [SlideShare]Commonwealth
May’s reports showed signs of continued economic growth, said Sam Millette, director, fixed income, in his latest Economic Risk Factor Update.
For more market updates, subscribe to The Independent Market Observer at https://blog.commonwealth.com/independent-market-observer.
Falcon stands out as a top-tier P2P Invoice Discounting platform in India, bridging esteemed blue-chip companies and eager investors. Our goal is to transform the investment landscape in India by establishing a comprehensive destination for borrowers and investors with diverse profiles and needs, all while minimizing risk. What sets Falcon apart is the elimination of intermediaries such as commercial banks and depository institutions, allowing investors to enjoy higher yields.
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby...Donc Test
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby, Hodge, Verified Chapters 1 - 13, Complete Newest Version Solution Manual For Financial Accounting, 8th Canadian Edition by Libby, Hodge, Verified Chapters 1 - 13, Complete Newest Version Solution Manual For Financial Accounting 8th Canadian Edition Pdf Chapters Download Stuvia Solution Manual For Financial Accounting 8th Canadian Edition Ebook Download Stuvia Solution Manual For Financial Accounting 8th Canadian Edition Pdf Solution Manual For Financial Accounting 8th Canadian Edition Pdf Download Stuvia Financial Accounting 8th Canadian Edition Pdf Chapters Download Stuvia Financial Accounting 8th Canadian Edition Ebook Download Stuvia Financial Accounting 8th Canadian Edition Pdf Financial Accounting 8th Canadian Edition Pdf Download Stuvia
[4:55 p.m.] Bryan Oates
OJPs are becoming a critical resource for policy-makers and researchers who study the labour market. LMIC continues to work with Vicinity Jobs’ data on OJPs, which can be explored in our Canadian Job Trends Dashboard. Valuable insights have been gained through our analysis of OJP data, including LMIC research lead
Suzanne Spiteri’s recent report on improving the quality and accessibility of job postings to reduce employment barriers for neurodivergent people.
Decoding job postings: Improving accessibility for neurodivergent job seekers
Improving the quality and accessibility of job postings is one way to reduce employment barriers for neurodivergent people.
Understanding how timely GST payments influence a lender's decision to approve loans, this topic explores the correlation between GST compliance and creditworthiness. It highlights how consistent GST payments can enhance a business's financial credibility, potentially leading to higher chances of loan approval.
1. Elemental Economics - Introduction to mining.pdfNeal Brewster
After this first you should: Understand the nature of mining; have an awareness of the industry’s boundaries, corporate structure and size; appreciation the complex motivations and objectives of the industries’ various participants; know how mineral reserves are defined and estimated, and how they evolve over time.
Using analytics to_track_monitor_and_reduce_costs_final
1. Using
Analy+cs
to
Track,
Monitor,
and
Reduce
Costs
Anne
Kirby
Chief
Compliance
Officer
and
Vice
President,
Medical
Review
Services,
Rising
Medical
Solu+ons
James
Masingill
Vice
President,
Claims
Opera+ons,
Market
First
Comp
Insurance
Company
Joe
Anderson
Director
of
Analy+cal
Services,
Progressive
Medical
Dr.
Robert
Hall
Medical
Director,
Progressive
Medical
2. Learning
Objec<ves
• Iden+fy
warning
signs
of
misuse
and
abuse
and
how
claim
managers
can
take
ac+on.
• Tell
how
payers
can
use
effec+ve
analy+cs
to
iden+fy
relevant
trends.
• Explain
how
Pharmacy
Benefit
Managers
can
use
analy+cs
with
strong
clinical
programs.
• Describe
the
role
and
benefits
of
predic+ve
analy+cs
in
the
workers’
compensa+on
industry.
3. Disclosure
Statement
• Anne
Kirby
has
no
financial
rela+onships
with
proprietary
en++es
that
produce
health
care
goods
and
services.
• James
Masingill
has
no
financial
rela+onships
with
proprietary
en++es
that
produce
health
care
goods
and
services.
• Joe
Anderson
has
no
financial
rela+onships
with
proprietary
en++es
that
produce
health
care
goods
and
services.
• Robert
Hall
has
no
financial
rela+onships
with
proprietary
en++es
that
produce
health
care
goods
and
services.
3
4. Using
Analy<cs
to
Track,
Monitor,
and
Reduce
Costs
Anne
Kirby,
RN
Chief
Compliance
Officer/VP
of
Medical
Review
Services
Rising
Medical
Solu+ons
5. Accepted
Learning
Objec+ves
1. Iden+fy
warning
signs
of
misuse
and
abuse
and
how
claim
managers
can
take
ac+on.
2. Tell
how
payers
can
use
effec+ve
analy+cs
to
iden+fy
relevant
trends.
3. Explain
how
Pharmacy
Benefit
Managers
can
use
analy+cs
with
strong
clinical
programs.
4. Describe
the
role
and
benefits
of
predic+ve
analy+cs
in
the
workers’
compensa+on
industry.
7. Challenge
for
Claims
Claims
with
long-‐ac+ng
opioid
Rx
cost
9.3
+mes
more
than
claims
without
(Journal
of
Occupa+onal
&
Environmental
Medicine)
• Very
manual
process
• Case
selec+on
not
always
on
target
• Trea+ng
physicians
and
pain
mgmt
peer
reviewers
used
drug
names
inconsistently
• If
a
person
was
taking
1
or
2
opioids,
it
was
likely
they
were
taking
upwards
of
7
or
8
other
drugs
8. 5
Key
Problems
1. Difficult
to
iden+fy
claims
with
ques+onable
drug
use
before
cases
turn
into
large
losses
2. Too
+me
consuming
for
adjuster
to
find
at-‐risk
cases
3. Not
enough
to
have
a
pharmacist
contact
a
trea+ng
physician
4. Data not
comprehensive
enough –
need integrated approach
5. Viewing
opioids
in
a
vacuum
–
need
to
look
at
other
constella+on
of
drugs
9. Addressing
the
Problems
Rx
Intelligence
Analy+cs
1. Expedites
file
iden+fica+on
2. Flags
poten+ally
problema+c
claims
early
3. Adds
another
level
of
interven+on
4. Looks
beyond
just
opioids
5. Uses
data
to
intervene
11. Demonstrated
Impact
Effect
of
successful
peer-‐to-‐peer
conversa+on
(between
pain
management
physician
and
prescribing
physician)
Fills
before
interven<on
Fills
aFer
interven<on
12. Demonstrated
Impact
• Decreased
Rx
Refills
within
6-‐8
months
of
Peer-‐to-‐
Peer
Review
65%
Claims
• Decreased
Opioid
Rx
Refills
71%
Claims
• Decrease
of
All
Injury
Related
Drugs
• Opioids,
Muscle
Relaxants,
Hypno<cs
&
57%
An<-‐Anxiety
meds
Claims
13. Connec+ng
the
Dots
Where
do
we
go
from
here?
Treati
ng Pain Mgmt
Physi Peer
Clai cian Reviewer
ms UR Nurse
Pers
on
PATI
Pharmac TCM
ENT
y Benefit Nurse
Mgr Clinical
Pharmaci
st
14. Using
Analy<cs
to
Track,
Monitor,
and
Reduce
Costs
Jamey
Masingill
Vice
President
of
Claims
Markel-‐FirstComp
Insurance
15. Accepted
Learning
Objec+ves
1. Iden+fy
warning
signs
of
misuse
and
abuse
and
how
claim
managers
can
take
ac+on.
2. Tell
how
payers
can
use
effec+ve
analy+cs
to
iden+fy
relevant
trends.
3. Explain
how
Pharmacy
Benefit
Managers
can
use
analy+cs
with
strong
clinical
programs.
4. Describe
the
role
and
benefits
of
predic+ve
analy+cs
in
the
workers’
compensa+on
industry.
18. Priming
the
Pump
by
Extrac+ng
“Old
School”
Thinking
from
the
Claims
Environment
• There
is
no
right
or
wrong…only
grey
• Reduce
ac+vity
checks
and
surveillance
• Targeted
and
directed
case
management
• Own
your
data
– Driven
down
to
unit
and
individual
levels
• Adherence
to
established
best
prac+ces
• Valida+on
process
22. Notes
Only
Presenta+on
Outline:
• Preparing
the
claims
environment
before
implemen+ng
your
program.
Analy+cs
and
program
will
only
be
effec+ve
if:
– Extract
“old
school”
thinking
from
claims
processing
– Reduce
ac+vity
checks
and
inves+ga+ons
– Redeploy
those
resources
into
added
medical
exper+se
/
interven+on
tools
• Using
claims
triangles
to
track
and
improve
performance
• Importance
of
integrated
approach
from
mul+ple
angles
to
effec+vely
tackle
prescrip+on
drug
problem
• Impact
on
overall
costs
23. Using
Analy<cs
to
Track,
Monitor,
and
Reduce
Costs
Joe
Anderson,
Director
of
Analy<cs
Robert
Hall,
MD,
Medical
Director
Progressive
Medical,
Inc.
24. Learning
Objec<ves
• Iden+fy
warning
signs
of
misuse
and
abuse
and
how
claim
managers
can
take
ac+on.
• Tell
how
payers
can
use
effec+ve
analy+cs
to
iden+fy
relevant
trends.
• Explain
how
Pharmacy
Benefit
Managers
can
use
analy+cs
with
strong
clinical
programs.
• Describe
the
role
and
benefits
of
predic+ve
analy+cs
in
the
workers’
compensa+on
industry.
26. What
Is
Predic<ve
Analy<cs?
Predictive Analytics is making decisions with statistics and data.
Company
Goal
of
predic<ve
analy<cs
Result
Target
Iden+fy
new
mothers
as
quickly
as
Delivered
coupons
to
young
possible
to
get
them
in
the
habit
of
mothers
before
their
family
even
shopping
at
Target.
knew
they
were
expec+ng.
Nemlix
Determine
which
movies
customers
Improved
their
predic+ons
by
10%;
will
like
based
on
what
they
have
a
$1
million
prize
was
awarded.
already
rated.
Oakland
Choose
the
best
baseball
players
20
consecu+ve
wins;
the
book
and
Athle+cs
available
for
the
next
season,
with
a
film
Moneyball
are
based
on
this.
limited
budget.
Sources:
Duhigg,
C.,
How
Companies
Learn
Your
Secrets,
The
New
York
Times
Magazine.
2012
February
16
Lohr,
S.,
A
$1
Million
Research
Bargain
for
NeElix,
and
Maybe
a
Model
for
Others,
The
New
York
Times,
2009
September
21
Mahler,
J.,
Smaller
Markets
and
Smarter
Thinking,
The
New
York
Times,
2011
October
14
27. How
Can
We
Use
It?
• As
a
PBM,
we
see
some
of
the
data
going
through
the
system,
but
not
all
of
it.
• Each
company
in
the
industry
can
use
analy+cs
with
their
own
data:
– Imagine
if
Nemlix
wants
to
know
whether
you’ll
enjoy
the
movie
Moneyball
– Nemlix
doesn’t
know
if
you
have
read
the
book
Moneyball,
if
you
studied
sta+s+cs
or
if
you’re
an
Oakland
Athle+cs
fan
– They
do
know
if
you
like
other
baseball
movies,
other
Brad
Pir
movies
and
other
movies
based
on
nonfic+on
books
Image source: http://www.managedcaremag.com/archives/1208/1208.pbm-functions.html
28. The
Problem
A
solu<on
is
needed
that
reduces
prescrip<ons
most
efficiently.
Prescrip<on
Drug
Deaths
and
Time
Constraints
on
Nurses,
Increasing
Costs
Adjustors,
Clinicians
• More
people
are
dying
from
• Cannot
examine
or
intervene
on
prescrip+on
drug
use.
every
claim
• Prescrip+on
drug
prices
are
rising.
• Cannot
determine
which
claims
will
• Workers’
compensa+on
in
par+cular
have
high
long-‐term
costs
has
seen
increases
in
use
of
• Too
many
“false
posi+ves”
from
prescrip+on
pain
killers.
individual
clinical
triggers
(i.e.
only
10%
of
claims
with
morphine
equivalence
of
90mg
result
in
high
long-‐term
costs)
29. The
Solu<on:
Mul<variate
Sta<s<cal
Model
to
Predict
High-‐Cost
Claims
Our
original
model,
since
refined:
Correlate
early
data
…
with
resul<ng
long-‐
about
an
injured
term
spend
of
that
worker…
injured
worker.
Workers
injured
in
2007
Resul+ng
pharmacy
costs
in
2009-‐2010
30. Data
Used
in
Sta<s<cal
Models
100%
90%
80%
70%
Pharmacy
Behavior:
Medica+ons,
Percent
of
Number
of
Prescribers,
Number
of
Significance
60%
Pharmacies
(Aggregated
across
mul<ple
Injury:
Body
part,
nature
of
injury
variables)
50%
Prescriber:
Demographics
of
trea+ng
40%
prescriber
30%
Geographic
and
Other
Demographics
20%
10%
0%
1
4
6
9
12
18
24
Months
Since
Date
of
Injury
31. The
Risk
Score
Claim
Risk
Score
Reason
Allison
6.5
Mul+ple
Neck
Injury,
High
Total
Medica+on
Use
(Including
Narco+cs)
Bob
5.4
Con+nued
Medica+on
Use,
High
Risk
Prescriber:
Allergy
and
Immunology
Specialist
Cindy
5.0
Mul+ple
Prescribers
in
Early
Months,
High
Days
Supply
of
Various
Medica+ons
Dwayne
4.5
High
Risk
State
and
Moderate
Injury
Risk:
Dislocated
Disc
Elaine
3.9
Prescriber
Risk:
Pain
Management
Specialist,
High
Narco+cs
Use
To-‐Date
Frank
3.1
Moderate
Injury
Risk,
Demographic
Risk,
and
Prescriber
Risk:
Pain
Management
Specialist
32. Predic<ons
Become
Interven<ons
• Types
of
clinical
interven+ons:
• Claims
Professional
Outreach
• Physician
Outreach
• Drug
U+liza+on
Evalua+on
• Peer-‐to-‐Peer
Review
• Interven+ons
should
be
completed
as
soon
as
possible
to
avoid
any
developing
complica+ons.
33. Measuring
Effec<veness
Statistical Confidence that
Intervention Changes this Outcome
100%
90%
96%
80%
70%
70%
60%
50%
55%
40%
30%
20%
10%
0%
Cost
per
Claim
Morphine
Equivalence
per
Claim
Prescrip+ons
per
Claim
34. Analy<cs
From
a
Provider’s
Perspec<ve
• Finding
common
ground
with
analy+cs
and
providers
• Embracing
challenges
that
can
arise
with
analy+cs
35. Common
Ground
–
Data
Collec<on
• Personal
medical
history
• Family
history
• Social
history
• Physical
examina+on
• Diagnos+c
studies
36. Common
Ground
–
Risk
Assessment
Stroke
Modifiable
risk
factors
Non-‐modifiable
risk
factors
• High
blood
pressure
• Age
• Atrial
fibrilla+on
• Gender
• High
cholesterol
• Race
• Diabetes
• Family
history
• Atherosclerosis
• Previous
stroke
• Circula+on
problems
• Fibromuscular
dysplasia
• Tobacco
• Alcohol
• Patent
foramen
ovale
• Physical
inac+vity
• Obesity
Source: National Stroke Association, Am I at Risk for a Stroke? Stroke Risk Factors. 2013 March 18
37. Common
Ground
–
Outcome
Predictors
Stroke
• Poor
strength
recovery
predictors
– Severe
arm
weakness
at
onset
of
stroke
– No
hand
strength
4
weeks
aLer
stroke
• 30-‐day
mortality
– EKG
abnormali+es
– Brainstem
stroke
– Elevated
blood
glucose
in
non-‐diabe+c
pa+ents
Source: Zorowitz, R., Baerga, E., Cuccurullo, S., Stroke Rehabilitation, Physical Medicine and Rehabilitation Board
Review. New York. Demos Medical Publishing. 2004
38. Common
Ground
–
Outcome
Predictors
Stroke
• Nega+ve
predictors
for
return
to
work
– Low
Barthel
Index
score
• Ac+vi+es
of
daily
living
– Prolonged
length
of
stay
in
rehabilita+on
– Aphasia
(language/communica+on
deficits)
– Prior
alcohol
abuse
Source: Zorowitz, R., Baerga, E., Cuccurullo, S., Stroke Rehabilitation, Physical Medicine and Rehabilitation Board
Review. New York. Demos Medical Publishing. 2004
39. Common
Ground
–
Language
• Data
collec+on
• Risk
assessment
• Risk
factors
• Outcome
predictors
• Interven+ons
• Behavior
• Effec+veness
40. Embracing
Challenges
Avoid
Blame
• Comprehensive
claim
evalua+on
• Interven+ons
may
need
to
be
mulNfaceted
41. Embracing
Challenges
Validate
Success
• Hill
Physicians
Medical
Group
– 2,200
physicians
– 332,000
pa+ents
– Predic+ve
modeling
• Management
of
chronic
diseases
– Prospec+ve
Risk
Score
• Likelihood
of
pa+ent
using
physician
resources
in
future
• RNs
are
assigned
to
call
pa+ents
with
high
risk
scores
Source: Emswiler, T. and Nichols, L., Hill Physicians Medical Group: Independent Physicians Working to Improve Quality
and Reduce Costs, The Commonwealth Fund. 2009 March
42. Embracing
Challenges
Validate
Success
0.5
x
In-‐pa+ent
days
over
last
365
days
In-‐pa+ent
days
over
last
90
days
+
2
x
ER
days
over
last
365
days
ER
days
over
last
90
days
2
x
(Prospec+ve
Risk
Score
+
adjustment
factor)
= Priority
Score
Source: Emswiler, T. and Nichols, L., Hill Physicians Medical Group: Independent Physicians Working to Improve Quality
and Reduce Costs, The Commonwealth Fund. 2009 March
43. Embracing
Challenges
Validate
Success
• Diabe+c
pa+ents
– High
Priority
Score
– Contacted
by
nurse
case
managers
– Reminders
for
screenings
• Eyes
• Kidneys
• Cholesterol
– Counseling
with
diabetes
educator
Source: Emswiler, T. and Nichols, L., Hill Physicians Medical Group: Independent Physicians Working to Improve Quality
and Reduce Costs, The Commonwealth Fund. 2009 March
44. Embracing
Challenges
Be
Responsive
• A
provider’s
ques+ons
– Is
my
prac+ce
style
being
ques+oned?
– Will
the
care
of
my
pa+ents
be
affected?
– Where
is
the
evidence?
– Why
now?
45. Embracing
Challenges
Reward
Posi<ve
Outcomes
• Should
providers
be
rewarded?
– Pay
for
performance
• Physician
payments
at
the
group
level
(not
individual)
• Mee+ng
absolute
benchmarks
• Soon
auer
performance
period
– Preferred
provider
status
• Recogni+on
• Increased
referrals
Source: Gamble, M., GAO: 3 Ways CMS Can Incentivize Physicians Like Private Payors, Becker's Hospital
Review, ASC COMMUNICATIONS. 2012 January 7; 2013 March 11
46. Takeaways
• Common
ground
– Data
collec+on
– Risk
assessment
– Outcome
predictors
– Language
• Embracing
challenges
– Avoid
blame
– Validate
success
– Be
responsive
– Reward
posi+ve
outcomes